Survival and quality of life for patients with peripheral type chronic thromboembolic pulmonary hypertension

Circulation Journal

Volumn 72, Issue 6, 2008, Pages 958-965

  Yoshimi, Seishi ^a   Tanabe, Nobuhiro ^a   Masuda, Masahisa ^a   Sakao, Seiichiro ^a   Uruma, Takahiro ^a   Shimizu, Hidefumi ^a   Kasahara, Yasunori ^a   Takiguchi, Yuichi ^a   Tatsumi, Koichiro ^a   Nakajima, Nobuyuki ^a   Kuriyama, Takayuki ^a  

^a CHIBA UNIVERSITY   (Japan)

Author keywords

Chronic thromboembolic pulmonary hypertension; Prognosis; Quality of life

Indexed keywords

ADULT; AGED; ARTICLE; CHRONIC DISEASE; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; DYSPNEA; ENDARTERECTOMY; FEMALE; FOLLOW UP; HUMAN; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; PULMONARY HYPERTENSION; QUALITY OF LIFE; SHORT FORM 36; SURGICAL MORTALITY; SURVIVAL; THROMBOEMBOLISM; TREATMENT INDICATION;

ACTIVITIES OF DAILY LIVING; ADOLESCENT; ADULT; AGED; ANTICOAGULANTS; ANTIHYPERTENSIVE AGENTS; CHRONIC DISEASE; ENDARTERECTOMY; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERTENSION, PULMONARY; KAPLAN-MEIERS ESTIMATE; MALE; MIDDLE AGED; MOTOR ACTIVITY; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PULMONARY EMBOLISM; QUALITY OF LIFE; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; THROMBECTOMY; VASODILATOR AGENTS;

EID: 45849136294     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.72.958     Document Type: Article

References (32)

1. Moser KM, Auger WR, Fedullo PF. Chronic major-vessel thromboembolic pulmonary hypertension. Circulation 1990; 81: 1735-1743.
2. Moser KM, Auger WR, Fedullo PF, Jamieson SW. Chronic thromboembolic hypertension: Clinical picture and surgical treatment. Eur Respir J 1992; 5: 334-342.
3. Fedullo PF, Auger WR, Kerr KM, Rubin LJ. Chronic thromboembolic pulmonary hypertension. N Engl J Med 2001: 345: 1465-1472.
4. Tanabe N, Kimura A, Amano S, Okada O, Kasahara Y, Tatsumi K, et al. Association of clinical features with HLA in chronic pulmonary thromboembolism in Japan. Eur Respir J 2005; 25: 131-138.
5. Tapson VF, Humbert M. Incidence and prevalence of chronic thromboembolic pulmonary hypertension: Grom acute to chronic pulmonary embolism. Proc Am Thorac Soc 2006; 32: 564-567.
6. Jamieson SW, Auger WR, Fedullo PF, Channick RN, Kriett JM, Tarazi RY, et al. Experience and results with 150 pulmonary thromboendarterectomy operations over a 29-month period. J Thorac Cardiovasc Surg 1993; 106: 116-127.
7. Hartz RS, Byrne JG, Levtsky S, Park J, Rich S. Predictors of mortality in pulmonary thromboendarterectomy. Ann Thorac Surg 1996; 62: 1255-1260.
8. Tanabe N, Okada O, Nakagawa Y, Masuda M, Kato K, Nakajima N, et al. The efficacy of pulmonary thromboendarterectomy on long-term gas exchange. Eur Respir J 1997; 10: 2066-2072.
9. Nakajima N, Masuda M, Mogi K. The surgical treatments for chronic pulmonary thromboembolism: Our experience and current review of the literature. Ann Thorac Cardiovasc Surg 1997; 3: 15-21.
10. Hooper MM, Mayer E, Gerald S, Rubin LJ. Chronic thromboembolic pulmonary hypertension. Circulation 2006; 113: 2011-2020.
11. Reesink HJ, Meijer RC, Lutter R, Boomsma F, Jansen HM, Kloek JJ, et al. Hemodynamic and clinical correlates of endothelin-1 in chronic thromboembolic pulmonary hypertension. Circ J 2006; 70: 1058-1063.
12. Bergin CJ, Dirlin C, Deutsch R, Fedullo P, Hauschild J, Huynh T, et al. Predictors of patient response to pulmonary thromboendarterectomy. AJR Am J Roentgenol 2000; 174: 509-515.
13. Riedel M, Stanek V, Widimsky J, Prerovsky I. Long-term follow-up of patients with pulmonary thromboembolism: Late prognosis and evolution of hemodynamic and respiratory data. Chest 1982; 81: 151-158.
14. Nakanishi N, Kyotani S, Satoh T, Kunieda T. Pulmonary hemodynamics and long-term outcome in patients with chronic pulmonary thromboembolism and pulmonary hypertension. Jpn J Thorac Dis 1997; 35: 589-595.
15. Lewczuk J, Piszko P, Jagans J, Poranda A, Wojciak S, Sobkowicz B, et al. Prognostic factors in medically treated patients with chronic pulmonary thromboembolism. Chest 2001; 119: 818-823.
16. Ono F, Nagaya N, Okumura H, Shimizu Y, Kyotani S, Nakanishi N, et al. Effect of orally active prostacyclin analogue on survival in patients with chronic thromboembolic pulmonary hypertension without major vessel obstruction. Chest 2003; 123: 1583-1588.
17. Nagaya N, Sasaki N, Ando M, Ogino J, Sakamaki F, Kyotani S, et al. Prostacyclin therapy before pulmonary thromboendarterectomy in patients with chronic thromboembolic pulmonary hypertension. Chest 2003; 123: 338-343.
18. Bresser P, Fedullo PF, Auger WR, Channick RN, Robbins IM, Kerr KM, et al. Continuous intravenous epoprostenol for chronic thromboembolic pulmonary hypertension. Eur Respir J 2004; 23: 595-600.
19. Ghofrani HA, Schermuly RT, Rose F, Wiedemann R, Kohstall MG, Kreckel A, et al. Sildenafil for long-term treatment of non-operable chronic thromboembolic pulmonary hypertension. Am J Respir Crit Care Med 2003; 167: 1139-1141.
20. Hoeper MM, Kramm T, Heinrike W, Schulze C, Schafers HJ, Welte T, et al. Bosentan therapy for inoperable chronic thromoboembolic pulmonary hypertension. Chest 2005; 128: 2363-2367.
21. Bonderman D, Nowotny R, Skoro-Sajer N, Jakowitsch J, Adlbrecht C, Klepetko W, et al. Bosentan therapy for inoperable chronic thromboembolic pulmonary hypertension. Chest 2005; 128: 2599-2603.
22. Hughes R, George P, Parameshwar J, Cafferty F, Dunning J, Morrell NW, et al. Bosentan in inoperable chronic thromboembolic pulmonary hypertension. Thorax 2005; 60: 707.
23. Auger WR, Fedullo PF, Moser KM, Buchbinder M, Peterson KL. Chronic major-vessel thromboembolic pulmonary artery obstruction: Appearance at angiography. Radiology 1992; 182: 393-398.
24. Yasui T, Tanabe N, Terada J, Yanagawa N, Shimizu H, Matsubara H, et al. Multidetector-row computed tomography management of acute pulmonary embolism. Circ J 2007; 71: 1948-1954.
25. Ware JE, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). Med Care 1992; 30: 473-483.
26. Fukuhara S, Bito S, Green J, Hsiao A, Kurokawa K. Translation, adaptation, and validation of the SF-36 Health Survey for use in Japan. J Clin Epidemiol 1998; 11: 1037-1044.
27. Fukuhara S, Suzukamo Y, Bito S, Kurokawa K. Manual of SF-36 Japanese version 1.2. Tokyo: Public Health Research Foundation, 2001.
28. Mahler DA, Weinberger DH, Wells CK, Feinstein AR. The measurement of dyspnea: Contents, interobserver agreement, and physiologic correlates of two new clinical indexes. Chest 1984; 85: 751-758.
29. Archibald CJ, Auger WR, Fedullo PF, Channick RN, Kerr KM, Jamieson SW, et al. Long-term outcome after pulmonary thromboendarterectomy. Am J Respir Crit Care Med 1999; 160: 523-528.
30. Thistlethwaite PA, Mo M, Madani MM, Deutsch R, Blanchard D, Kapelanski DP, et al. Operative classification of thromboembolic disease determines outcome after pulmonary endarterectomy. J Thorac Cardiovasc Surg 2002; 124: 1203-1211.
31. Tanabe N, Amano S, Tatsumi K, Kominami S, Igarashi N, Shimura R, et al. Angiotensin-converting enzyme gene polymorphisms and prognosis in chronic thromboembolic pulmonary hypertension. Circ J 2006; 70: 1174-1179.
32. Ogino H, Ando M, Matsuda H, Minatoya K, Sasaki H, Nakanishi N, et al. Japanese single-center experience of surgery for chronic thromoboembolic pulmonary hypertension. Ann Thorac Surg 2006; 82: 630-636.